Simplify Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Simplify Asset Management's REGN Position: Q2 2026 in Review
Simplify Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 10,900 shares — an estimated $8.42M sold.
Simplify Asset Management first reported a position in REGN in Q2 2022 and held it in 16 quarters. The position peaked at $24M in Q4 2025. 729 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Simplify Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Simplify Asset Management sold 10,900 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $8.42M.
- Simplify Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2022 and held it in 16 quarters.
- Simplify Asset Management's Regeneron Pharmaceuticals position peaked at $24M in Q4 2025.
- 729 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.